Back

prof. dr. M.G.E.H. (Marnix) Lam

prof. dr. M.G.E.H. (Marnix) Lam

Full Professor
prof. dr. M.G.E.H. (Marnix) Lam
  • Research group Nuclear Medicine

Research Programs

Cancer

Biography

Biography

Marnix Lam (1975) studied Pharmaceutical sciences (passed with distinction) and Medicine at Utrecht University. He became a resident in Nuclear Medicine, respectively Radiology and finalized his PhD thesis (2009) on radionuclide therapy in prostate cancer patients with metastatic bone pain. This was followed by a two-year postdoctoral fellowship at Stanford University School of Medicine, USA. In 2016 he was appointed Professor of Nuclear Medicine.
Translational research in molecular medicine has been the scope of his scientific work, with a focus on oncology. Bringing new radiopharmaceuticals to clinical practice. This specifically resulted in the introduction of new oncological treatment modalities in the Netherlands, such as bone seeking radiopharmaceuticals for the palliation of metastatic bone pain (Sm-153-EDTMP, Re-188-HEDP) and radioembolization for treatment of hepatic malignancies (Y-90 and Ho-166 microspheres). Current research is focussed on dosimetry of therapeutic radiopharmaceuticals, image-guided treatment technology, alfa- and beta-emitting isotopes for therapeutic purposes, intra-arterial and intra-tumor treatment approaches, and radio-immunotherapy.

Side Activities

Public Private Partnerships

Consultancy / (scientific) advisory board meetings and research support from Terumo / Quirem Medical B.V. No personal financial compensation, only the department of Radiology and Nuclear Medicine of the UMC Utrecht is financially compensated for these services.

Consultancy / (scientific) advisory board meetings and research support from Boston Scientific. No personal financial compensation, only the department of Radiology and Nuclear Medicine of the UMC Utrecht is financially compensated for these services.

Research support from Novartis. No personal financial compensation.

The department of Radiology and Nuclear Medicine of the UMC Utrecht receives royalties and milestone payments from Terumo / Quirem Medical B.V. No personal financial compensation.

Educational activities

Board Member of the National Education Committee on Nuclear Medicine. No personal financial compensation.

Memberships of professional societies

Member of the Dutch society of Nuclear Medicine: ‘De Nederlandse Vereniging voor Nucleaire Geneeskunde (NVNG)’. No personal financial compensation.

Member of the Royal Dutch society for promotion of the medical profession: ‘De Koninklijke Nederlandse Maatschappij ter bevordering van de Geneeskunst (KNMG)’. No personal financial compensation.

Member of ‘the European Association of Nuclear Medicine (EANM)’. No personal financial compensation.

 

Fellowship and Awards

2021 - Research grant from ‘Zorginstituut, Veelbelovende zorg’: SIRT with 166Ho-microspheres in elderly and fragile patients with previously untreated unresectable liver-only metastases of colorectal cancer, CAIRO7 study of the Dutch Colorectal Cancer Group (DCCG)

2021 - Research grant from Quirem: clinical research on the safety and efficacy of holmium-166 (166Ho)-microspheres radioembolization in patients with hepatic malignancies. 

2021 - Research grant from Terumo: Individualized dosimetry for holmium-166 (166Ho)-radioembolization in patients with unresectable hepatocellular carcinoma; a multi-center, interventional, non-randomized, non-comparative, open label, early phase II study: iHEPAR. 

2021 - Research grant from Terumo: The RALLY study: Dose finding study for unilobar radiation lobectomy using holmium-166 (166H0)-microspheres to improve resectability in patients with HCC .

2020 - Research grant from Boston Scientific: Hepatic glass yttrium-90 (90Y)-microspheres radioembolization.

2020 - Awarded CVIR Editors’ Medal for 2020: Radioembolization with 90Y Resin Microspheres of Neuroendocrine Liver Metastases: International Multicenter Study on Efficacy and Toxicity. Braat, A.J.A.T., Kappadath, S.C., Ahmadzadehfar, H. et al. Cardiovasc Intervent Radiol (2019) 42(3).

2020 - Awarded Editors’ Choice Paper and top 10% downloaded papers in Medical Physics: Kunnen B et al. Feasibility of imaging 90Y microspheres at diagnositc activity levels for hepatic radioembolization treatment planning. Med Phys.

2019 - Alavi-Mandell award for best publication in Journal of Nuclear Medicine: Efficacy of Radioembolization with 166Ho-Microspheres in Salvage Patients with Liver Metastases: A Phase 2 Study. J Nucl Med. 2018 Apr;59(4):582-588.

2018 - Research grant from the Dutch Cancer Society (KWF): Diagnostic accuracy of Gallium-68 PSMA PET/CT in primary staging of prostate cancer

2018 - Research grant from NWO Industrial Doctorates program: Advanced dosimetry for personalized radioembolization treatment (ADOPT)

2018 - Research grant from BTG / Boston Scientific: LUMI DEBIRI and TheraSphere for treatment of metastatic colorectal cancer (DEBIRY)

2018 - Research grant from Health Holland program: Intra-arterial lutetium-177-dotatate for treatment of patients with neuroendocrine tumor liver metastases

2017 - Alavi-Mandell award for best publication in Journal of Nuclear Medicine: Insights into the dose-response relationship of radioembolization with resin yttrium-90 microspheres: a prospective cohort study in patients with colorectal cancer liver metastases. J Nucl Med. 2016 Jul;57(7):1014-9.

2016 - Research grant from the Dutch Cancer Society (KWF): Holmium-166 microspheres for radioembolization in HCC patients: new generation microspheres for individualized treatment

2016 Alavi-Mandell award for best publication in Journal of Nuclear Medicine: Safety of a Scout Dose Preceding Hepatic Radioembolization with 166Ho Microspheres. J Nucl Med. 2015 Jun;56(6):817-23.

2016 - Alavi-Mandell award for best publication in Journal of Nuclear Medicine: Impact of Personal Characteristics and Technical Factors on Quantification of Sodium 18F-Fluoride Uptake in Human Arteries: Prospective Evaluation of Healthy Subjects. J Nucl Med. 2015 Oct;56(10):1534-40.

2016 - Appointed as full professor of Nuclear Medicine at the University of Utrecht, The Netherlands

2014 - Research grant from Alpe d’Huzes / Dutch Cancer Society (KWF): Holmium micro-brachytherapy: an innovative intratumoral treatment modality in head and neck cancer

2014 - Appointed as honorary professor at the medical school of the People’s Liberation Army General Hospital and Military University, Beijing, China

2014 - CIRSE Award of Excellence and Innovation in Interventional Radiology

2010 - Research grant from the Dutch Cancer Society (KWF): translational research in oncology

Research Output (265)

Prophylactic Medication during Radioembolization in Metastatic Liver Disease:Is It Really Necessary? A Retrospective Cohort Study and Systematic Review of the Literature

Braat Manon N G J A, Ebbers Sander C, Alsultan Ahmed A, Neek Atal O, Bruijnen Rutger C G, Smits Maarten L J, de Bruijne Joep, Lam Marnix G E H, Braat Arthur J A T 12 Dec 2023, In: Diagnostics (Basel, Switzerland). 13

Dose finding study for unilobar radioembolization using holmium-166 microspheres to improve resectability in patients with HCC:the RALLY protocol

Andel Daan, Lam Marnix G.E.H., de Bruijne Joep, Smits Maarten L.J., Braat Arthur J.A.T., Moelker Adriaan, Vegt Erik, Ruiter Simeon J.S., Noordzij Walter, Grazi Gianluca, Vallati Giulio E., Bennink Roel J., van Delden Otto M., Kranenburg Onno W., Ijzermans Jan N.M., Nijkamp Maarten W., Erdmann Joris I., Sciuto Rosa, Hagendoorn Jeroen, Borel Rinkes Inne H.M. 18 Aug 2023, In: BMC Cancer. 23 , p. 1-9

Automatic healthy liver segmentation for holmium-166 radioembolization dosimetry

Stella Martina, van Rooij Rob, Lam Marnix G E H, de Jong Hugo W A M, Braat Arthur J A T 15 Jul 2023, In: EJNMMI Research. 13

Combining Selective Internal Radiation Therapy with Immunotherapy in Treating Hepatocellular Carcinoma and Hepatic Colorectal Metastases:A Systematic Review

Ramdhani Khalil, Smits Maarten L.J., Lam Marnix G.E.H., Braat Arthur J.A.T. 1 May 2023, In: Cancer biotherapy & radiopharmaceuticals. 38 , p. 216-224 9 p.

Fibroblast Activation Protein Inhibitor-PET Imaging in Colorectal Cancer

Strating Esther, van de Loo Anne, Elias Sjoerd, Lam Marnix, Kranenburg Onno 6 Apr 2023, In: PET Clinics. 18 , p. 325-335 11 p.

Tolerability of concurrent external beam radiotherapy and [ 177Lu]Lu-PSMA-617 for node-positive prostate cancer in treatment naïve patients, phase I study (PROQURE-I trial).

van der Sar Esmée C A, Braat Arthur J A T, van der Voort-van Zyp Jochem R N, van der Veen Betty S, van Leeuwen Pim J, de Vries-Huizing Daphne M V, Hendrikx Jeroen M A, Lam Marnix G E H, Vogel Wouter V 23 Mar 2023, In: BMC Cancer. 23

Lutetium-177-PSMA bij gemetastaseerd prostaatcarcinoom

van Golen Larissa W., Vogel Wouter, Lam Marnix G.E.H. 16 Mar 2023, In: Nederlands Tijdschrift voor Geneeskunde. 166

Evaluating the Targeting of a Staphylococcus-aureus-Infected Implant with a Radiolabeled Antibody In Vivo

van Dijk Bruce, Hooning van Duyvenbode J. Fred F., de Vor Lisanne, Nurmohamed F. Ruben H.A., Lam Marnix G.E.H., Poot Alex J., Ramakers Ruud M., Koustoulidou Sofia, Beekman Freek J., van Strijp Jos, Rooijakkers Suzan H.M., Dadachova Ekaterina, Vogely H. Charles, Weinans Harrie, van der Wal Bart C.H. Mar 2023, In: International journal of molecular sciences. 24 , p. 1-9 9 p.

Correction to:[ <sup>18</sup>F]mFBG PET‑CT for detection and localisation of neuroblastoma: a prospective pilot study (European Journal of Nuclear Medicine and Molecular Imaging, (2023), 50, 4, (1146-1157), 10.1007/s00259-022-06063-6)

Samim Atia, Blom Thomas, Poot Alex J, Windhorst Albert D, Fiocco Marta, Tolboom Nelleke, Braat Arthur J A T, Viol Sebastiaan L Meyer, van Rooij Rob, van Noesel Max M, Lam Marnix G E H, Tytgat Godelieve A M, de Keizer Bart 18 Feb 2023, In: European Journal of Nuclear Medicine and Molecular Imaging. 50 , p. 1-1 1 p.

PSMA-PET:aanwinst voor de prostaatkankerdiagnostiek

van der Sar Esmée C.A., Lavalaye Jules, Braat Arthur J.A.T., de Klerk John M.H., Lam Marnix G.E.H., de Keizer Bart 4 Jan 2023, In: Nederlands Tijdschrift voor Geneeskunde. 167 4 p.

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not